Pharmaceutical and chemical industries to give evidence on future UK-EU trade to Lords EU Committee
On Monday 22 June 2020 representatives from the pharmaceutical and chemical industries will be giving evidence to the House of Lords EU Goods Sub-Committee's inquiry on how to facilitate future UK-EU trade in manufactured goods.
- This session will be held remotely and streamed on Parliament TV.
At 10.30am the Committee will hear from:
- Dr Louise Gill, Head of Policy, Global Regulatory Affairs, GlaxoSmithKline
- Richard Ayton, Director of Government Affairs, Dow Chemical UK and Ireland.
Possible questions that may be asked by the Committee include:
- How will non-tariff barriers affect the pharmaceutical and chemical industries at the end of the transition period? How costly could they be?
- What steps have you taken to prepare for the end of the transition period? Is there anything the Government could do to support businesses in their preparations?
- How important is formal UK-EU regulatory cooperation for your businesses and what specific regulatory provisions would you like to see in the UK-EU trade agreement?
- How important is UK-EU cooperation on market surveillance and what form should this take?
- What unilateral measures could the UK take to reduce the regulatory barriers to UK-EU trade in the pharmaceutical and chemical sectors?
On Tuesday 26 May 2020 the Committee invited written contributions to this inquiry. Read the full call for evidence and find out how to submit evidence.
